Phase II Study Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer

Theodore S. Hong, MD of Massachusetts General Hospital outlines a Phase II Study of Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer at ASCO GI 2017... Author: ASCOGI2017 Added: 01/26/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts